0000000000287164

AUTHOR

Jörg Wenzel

showing 4 related works from this author

Travel‐associated infectious skin diseases

2020

Travelmedicine.medical_specialtybusiness.industryDermatologySkin DiseasesDermatologyInfectious skin diseasesHumansMedicineddc:610Skin Diseases InfectiousTravel-Related IllnessbusinessTravel MedicineJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Diagnostics of autoimmune bullous diseases in German dermatology departments

2012

Summary Background: No consistent data are available on the currently employed diagnostic tools for autoimmune bullous diseases in Germany. The aim of this survey was to describe currently performed diagnostic methods for bullous autoimmune diseases in German dermatology departments. Methods: A standardized questionnaire evaluated the available diagnostic methods i. e. direct immunofluorescence microscopy (IFM), indirect IFM, commercial ELISA systems, and non-commercial serological tests as well as the number of samples per year in all 34 university and 39 non-university dermatology departments. Results: The overall return rate was 89 %, 100 % and 79 % for the university and non-university …

Pemphigoidmedicine.medical_specialtyDiagnostic methodsbusiness.industryDiagnostic testDermatologymedicine.diseaseDiagnostic toolsDermatologyhumanities3. Good healthSerology030207 dermatology & venereal diseases03 medical and health sciencesPemphigus0302 clinical medicine030220 oncology & carcinogenesisMedicineBullous pemphigoidbusinessDirect fluorescent antibodyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Diagnostik blasenbildender Autoimmundermatosen an deutschen Hautkliniken

2012

DermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin

2005

We evaluated the efficacy of a candidate melanoma vaccine approach in mice genetically prone to develop melanoma due to the introduction of an oncogenic mutation (R24C) in the germline sequence of the cyclin-dependent kinase 4 (cdk4), a protein critically involved in cell cycle regulation. Melanomas were induced in cdk4-mutant mice by chemical carcinogenesis and UVB irradiation. A genetic prime-boost strategy targeting the clinically relevant differentiation antigen tyrosinase-related protein 2 (TRP2) was performed which was able to stimulate a melanocyte-specific cellular immune response associated with localized autoimmune vitiligo-like depigmentation. However, significant destruction of …

Cancer ResearchSkin NeoplasmsUltraviolet Raysmedicine.medical_treatmentCancer VaccinesMelanoma VaccineDNA vaccinationMiceImmune systemDepigmentationAntigenImmune TolerancemedicineAnimalsGenetic Predisposition to DiseaseMelanomaneoplasmsGerm-Line MutationMice Knockoutbusiness.industryMelanomaCell CycleCyclin-Dependent Kinase 4Neoplasms ExperimentalImmunotherapymedicine.diseaseIntramolecular OxidoreductasesMice Inbred C57BLDisease Models AnimalOncologyImmunologyCarcinogensSkin cancermedicine.symptombusinessInternational Journal of Cancer
researchProduct